Tenascin-C Is a Novel RBPJκ-Induced Target Gene for Notch Signaling in Gliomas
Open Access
- 15 January 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (2) , 458-465
Abstract
Tenascin-C (TNC) expression is known to correlate with malignancy in glioblastoma (GBM), a highly invasive and aggressive brain tumor that shows limited response to conventional therapies. In these malignant gliomas as well as in GBM cell lines, we found Notch2 protein to be strongly expressed. In a GBM tumor tissue microarray, RBPJk protein, a Notch2 cofactor for transcription, was found to be significantly coexpressed with TNC. We show that the TNC gene is transactivated by Notch2 in an RBPJk-dependent manner mediated by an RBPJk binding element in the TNC promoter. The transactivation is abrogated by a Notch2 mutation, which we detected in the glioma cell line Hs683 that does not express TNC. This L1711M mutation resides in the RAM domain, the site of interaction between Notch2 and RBPJk. In addition, transfection of constructs encoding activated Notch2 or Notch1 increased endogenous TNC expression identifying TNC as a novel Notch target gene. Overexpression of a dominant negative form of the transcriptional coactivator MAML1 or knocking down RBPJk in LN319 cells led to a dramatic decrease in TNC protein levels accompanied by a significant reduction of cell migration. Because addition of purified TNC stimulated glioma cell migration, this represents a mechanism for the invasive properties of glioma cells controlled by Notch signaling and defines a novel oncogenic pathway in gliomagenesis that may be targeted for therapeutic intervention in GBM patients. [Cancer Res 2009;69(2):458–65]Keywords
This publication has 48 references indexed in Scilit:
- Critical Role of Notch Signaling in Osteosarcoma Invasion and MetastasisClinical Cancer Research, 2008
- Notch signaling mediates hypoxia-induced tumor cell migration and invasionProceedings of the National Academy of Sciences, 2008
- Tenascin-W Is a Novel Marker for Activated Tumor Stroma in Low-grade Human Breast Cancer and Influences Cell BehaviorCancer Research, 2007
- Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain TumorsPLOS ONE, 2007
- Contribution of Notch signaling activation to human glioblastoma multiformeJournal of Neurosurgery, 2007
- High TGFβ-Smad Activity Confers Poor Prognosis in Glioma Patients and Promotes Cell Proliferation Depending on the Methylation of the PDGF-B GeneCancer Cell, 2007
- Notch Signaling Enhances Nestin Expression in GliomasNeoplasia, 2006
- NOTCH2 Mutations Cause Alagille Syndrome, a Heterogeneous Disorder of the Notch Signaling PathwayThe American Journal of Human Genetics, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Tenascin‐C in serum: A questionable tumor markerInternational Journal of Cancer, 1995